Viewing nowCombinationExfin Tablet 5/160mg (Amlodipine Besilate, Valsartan)
Valsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.

MFDS item code 201404969 · Approved 2014.10.27 · Insurance code 628900280
Treatment of essential hypertension inadequately controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or valsartan. In other words, it helps effectively control blood pressure in cases where it is difficult to manage blood pressure with monotherapy alone. This helps reduce the risk of complications due to hypertension and improves overall cardiovascular health.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time every day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before treatment with this drug. However, a direct switch to this drug may be considered if blood pressure is not adequately controlled with monotherapy using the individual components, as follows. ㆍ5/80 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater); however, do not administer this drug to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Exercise caution when increasing the dose.
The administration of this drug is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.
This drug may cause serious harm to the fetus and newborn during the 2nd and 3rd trimesters of pregnancy, therefore it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the ingredients in this medication or similar drugs, pregnant or nursing women, patients with severe kidney or liver diseases, or those with a history of certain heart conditions or angioedema should not take this drug. Patients with sodium or fluid depletion should correct their conditions before taking this drug, and if symptoms of hypotension occur, they should lie down immediately and receive intravenous fluid therapy if necessary. Patients with high serum potassium levels should be especially cautious when taking this drug along with potassium supplements or potassium-sparing diuretics, and they should frequently monitor their potassium levels. Patients with kidney issues or those who have received a kidney transplant, as well as those with a history of angioedema, should be cautious when taking this medication; if symptoms of angioedema occur, they should stop taking the medication immediately. Patients with heart failure or following a myocardial infarction should closely monitor kidney function and symptoms while on this medication, and patients with acute myocardial infarction should be careful as this medication may exacerbate angina or myocardial infarction symptoms. Like other vasodilators, this medication should be used with caution in patients with certain heart valve diseases. Taking this drug with other medications that have similar effects may increase the risk of hypotension, worsening kidney function, and hyperkalemia, so it is advised to avoid combination therapy or to frequently check blood pressure and kidney function under a doctor's guidance. Use caution when driving or operating machinery as dizziness or fatigue may occur. In case of overdose, severe hypotension or cardiac dysfunction may occur, and immediate medical assistance is required. Additionally, this medication is not recommended for children as its safety and efficacy have not been established, while older adults may receive similar dosing as in general adults.
Nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, sensory disturbance, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, pruritus, joint swelling, low back pain, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, dependent edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver enzyme levels, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory reduction, taste disturbance, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, nocturnal enuresis, gynecomastia, pain, lethargy, chest pain, weight loss, weight gain, elevated liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuroexcitation, sensory reduction, Stevens-Johnson syndrome, dizziness, fatigue, sudden decrease in blood pressure, hypotension, pulmonary edema, decreased urine output, progressive hyperazotemia, acute renal failure, death, angina, acute myocardial infarction, increased blood urea, increased serum creatinine, intestinal vascular edema, abdominal pain, nausea, vomiting, diarrhea, non-cardiogenic pulmonary edema, reflex tachycardia, systemic hypotension, shock
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature of between 1 to 30 degrees Celsius at room temperature.
Dark yellow oblong film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.